FLORENTAISE | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Home
Companies
FLORENTAISE

BRIEF

published on 10/18/2024 at 18:05, 1 month 2 days ago

Florentaise reports its annual results and reveals its quarterly turnover

Treasury Annual Results Turnover Florentine Seasonal
BRIEF

published on 07/25/2024 at 17:50, 3 months 26 days ago

Florentaise: 2023-2024 turnover up 15.5%

Florentaise Growth Turnover Sales China Rainfall France
BRIEF

published on 07/04/2024 at 18:05, 4 months 16 days ago

Florentaise: Growth in sales of peat-free potting soils

Florentaise Growth Professionals Potting Soil Without Peat
BRIEF

published on 05/13/2024 at 18:45, 6 months 7 days ago

FLORENTAISE: Expansion in China and ecological commitments

China Florentaise Carbon Credits Ecological Transition Biochar
PRESS RELEASE

published on 05/13/2024 at 18:40, 6 months 7 days ago

FLORENTAISE: The Group forms new partnerships and reinforces its regional footprint in China, in favour of the ecological transition
Florentaise strengthens its regional presence in China by forming new partnerships for eco-friendly initiatives, including biochar production and carbon credit generation

China Florentaise Partnerships Ecological Transition Biochar
BRIEF

published on 04/30/2024 at 17:50, 6 months 20 days ago

Florentaise announces significant growth in its turnover

Florentaise Growth Turnover Low Carbon Soils Sales In China
BRIEF

published on 04/17/2024 at 18:05, 7 months 3 days ago

Florentaise launches TERRASTIM, an innovative solution for urban floors

Florentaise Flomix TERRASTIM GREENCHAR Urban Revegetation
BRIEF

published on 03/28/2024 at 18:07, 7 months 23 days ago

FLORENTAISE announces growth and ambitious prospects for the 2nd half of 2023-2024

Revenue Growth Business Strategy Florentaise Half-year Results Ecological Innovation
BRIEF

published on 03/28/2024 at 18:05, 7 months 23 days ago

Florentaise’s 2023-2024 Half-Year Report posted online

Florentaise Financial Markets Half-yearly Report 2023-2024 Low Carbon Soils Financial Publication
BRIEF

published on 03/26/2024 at 18:05, 7 months 25 days ago

Florentaise announces the marketing authorization of Flomix, a biostimulant based on Hortifibre® strains

Florentaise Agriculture Environment Flomix Biostimulant

Accesswire

Published on 11/21/2024 at 13:30, 13 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 13 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 43 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 43 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 43 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 28 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 8 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 28 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 36 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 43 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE